NATH BIOGENES (INDIA)
Back to Income Statement
|
NATH BIOGENES (INDIA) Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2013 | |
|---|---|---|---|---|---|
| Net Sales | ₹365 Cr | ₹333 Cr | ₹301 Cr | ₹278 Cr | ₹138 Cr |
What is the latest Revenue of NATH BIOGENES (INDIA) ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹365 Cr |
| Mar2024 | ₹333 Cr |
| Mar2023 | ₹301 Cr |
| Mar2022 | ₹278 Cr |
| Mar2013 | ₹138 Cr |
How is Revenue of NATH BIOGENES (INDIA) Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹365 Cr | 9.71 | |
| Mar2024 | ₹333 Cr | 10.37 | |
| Mar2023 | ₹301 Cr | 8.26 | |
| Mar2022 | ₹278 Cr | 102.15 | |
| Mar2013 | ₹138 Cr | - | |
Compare Revenue of peers of NATH BIOGENES (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATH BIOGENES (INDIA) | ₹276.4 Cr | 2.5% | -6.4% | -16.6% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹11,696.2 Cr | -1.5% | -11.3% | -18.3% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,562.7 Cr | 6.1% | -10% | 4.3% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,130.2 Cr | 1.4% | -0.3% | -5% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹930.8 Cr | -3.5% | -15.7% | -41.2% | Stock Analytics | |
| INDO US BIOTECH | ₹240.7 Cr | -3.3% | -1.8% | -43.6% | Stock Analytics | |
NATH BIOGENES (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATH BIOGENES (INDIA) | 2.5% |
-6.4% |
-16.6% |
| SENSEX | -1% |
-4.7% |
6% |
You may also like the below Video Courses